2269 — WuXi Biologics (Cayman) Cashflow Statement
0.000.00%
Last trade - 00:00- HK$57.42bn
- HK$54.18bn
- CNY17.03bn
Annual cashflow statement for WuXi Biologics (Cayman), fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 1,127 | 1,966 | 3,993 | 5,358 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 154 | 73.8 | 270 | 943 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -294 | -461 | -1,313 | -1,560 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,208 | 1,881 | 3,431 | 5,542 | — |
| Capital Expenditures | -3,235 | -6,025 | -6,523 | -5,868 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -1,259 | -1,192 | -3,079 | -39.9 | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -4,494 | -7,216 | -9,602 | -5,908 | — |
| Financing Cash Flow Items | -8.44 | 160 | -104 | 508 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 5,413 | 6,566 | 8,209 | -2,592 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2,121 | 890 | 1,908 | -2,608 | — |